Fig. 2
From: Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
Sulbactam alone did not significantly affect cell viability of the breast cancer cell lines. a The MCF-10A cells treated with Sul (squares), Sul + D0.5 (triangles), and Sul + D1.0 (circles). The b MDA-MB-453 and c MDA-MB-468 cells treated with Sul (squares) and Sul + D0.5 (triangles). Data are expressed as the percentage of cell viability compared with negative control in which cell viability was assumed to be 100%. Reported values represent mean ± SD of at least three independent experiments. Sul sulbactam, Dox doxorubicin, MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, SD standard deviation
